Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)
NCT05705167
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
37
Enrollment
INDUSTRY
Sponsor class
Stopped
Significant difficulties in the recruitment of participants.
Conditions
COVID-19
Interventions
DRUG:
Plitidepsin
Sponsor
PharmaMar